Compare CRON & LMRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRON | LMRI |
|---|---|---|
| Founded | N/A | 2018 |
| Country | Canada | United States |
| Employees | N/A | 4335 |
| Industry | Medicinal Chemicals and Botanical Products | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 2015 | N/A |
| Metric | CRON | LMRI |
|---|---|---|
| Price | $2.79 | $12.18 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $20.75 |
| AVG Volume (30 Days) | ★ 935.3K | 762.4K |
| Earning Date | 05-11-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | ★ $146,587,000.00 | N/A |
| Revenue This Year | $26.34 | $6.35 |
| Revenue Next Year | $15.53 | $5.61 |
| P/E Ratio | $68.75 | ★ N/A |
| Revenue Growth | ★ 24.63 | N/A |
| 52 Week Low | $1.93 | $6.45 |
| 52 Week High | $3.43 | $19.45 |
| Indicator | CRON | LMRI |
|---|---|---|
| Relative Strength Index (RSI) | 53.34 | 66.11 |
| Support Level | $2.56 | $6.98 |
| Resistance Level | $2.92 | $16.38 |
| Average True Range (ATR) | 0.08 | 0.79 |
| MACD | 0.00 | 0.17 |
| Stochastic Oscillator | 51.56 | 81.63 |
Cronos Group Inc is a cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology, and product development. With a passion for responsibly elevating the consumer experience, the company is building an iconic brand portfolio. Its diverse international brand portfolio includes Spinach, PEACE NATURALS, LIT, and Lord Jones. The company operates in Canada, Israel, and other countries, with the majority of its revenue generated from Canada.
Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities, including MRI, CT, PET, X-ray, ultrasound, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties, mainly hospital imaging departments. The majority of revenue is generated by the Outpatient segment, which performs imaging studies and provides radiologists' interpretations of those studies.